Mawer Investment Management Ltd. boosted its position in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 11.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 525,172 shares of the company's stock after acquiring an additional 55,716 shares during the quarter. Mawer Investment Management Ltd. owned 0.20% of Ryan Specialty worth $27,115,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in RYAN. Advisory Services Network LLC bought a new position in Ryan Specialty in the third quarter valued at $28,000. SBI Securities Co. Ltd. boosted its position in Ryan Specialty by 6,322.2% during the fourth quarter. SBI Securities Co. Ltd. now owns 578 shares of the company's stock valued at $30,000 after buying an additional 569 shares during the period. Fifth Third Bancorp boosted its position in Ryan Specialty by 65.4% during the third quarter. Fifth Third Bancorp now owns 612 shares of the company's stock valued at $34,000 after buying an additional 242 shares during the period. Quarry LP purchased a new stake in Ryan Specialty during the third quarter valued at about $37,000. Finally, Hantz Financial Services Inc. boosted its position in Ryan Specialty by 878.2% during the third quarter. Hantz Financial Services Inc. now owns 851 shares of the company's stock valued at $48,000 after buying an additional 764 shares during the period. Institutional investors own 84.82% of the company's stock.
Ryan Specialty Stock Performance
Ryan Specialty stock opened at $33.09 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 2.90. The firm has a 50-day moving average of $33.70 and a 200-day moving average of $43.23. The firm has a market cap of $8.72 billion, a P/E ratio of 42.97, a P/E/G ratio of 0.77 and a beta of 0.64. Ryan Specialty Holdings Inc. has a 1-year low of $29.28 and a 1-year high of $72.50.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.04. The company had revenue of $795.23 million during the quarter, compared to analyst estimates of $781.44 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. Ryan Specialty's revenue for the quarter was up 15.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.39 earnings per share. Sell-side analysts expect that Ryan Specialty Holdings Inc. will post 2.04 EPS for the current year.
Ryan Specialty announced that its Board of Directors has approved a stock buyback program on Tuesday, May 26th that authorizes the company to repurchase $300.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 3.5% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its stock is undervalued.
Ryan Specialty Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were issued a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date was Tuesday, May 12th. Ryan Specialty's dividend payout ratio is currently 67.53%.
Analysts Set New Price Targets
Several research firms have issued reports on RYAN. Weiss Ratings restated a "sell (d+)" rating on shares of Ryan Specialty in a research report on Monday, May 4th. UBS Group set a $39.00 price target on shares of Ryan Specialty in a research report on Thursday, May 21st. Keefe, Bruyette & Woods restated an "outperform" rating on shares of Ryan Specialty in a research report on Tuesday, May 26th. The Goldman Sachs Group restated a "buy" rating and set a $42.00 price target on shares of Ryan Specialty in a research report on Friday, May 1st. Finally, BMO Capital Markets lowered shares of Ryan Specialty from an "outperform" rating to a "market perform" rating and cut their price target for the company from $66.00 to $43.00 in a research report on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, Ryan Specialty has a consensus rating of "Hold" and an average target price of $46.76.
Read Our Latest Stock Report on RYAN
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Group, Inc NYSE: RYAN is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.
Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Read More
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.